Vaishali Pharma Ltd vs Vilin Bio Med Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Vaishali Pharma Ltd is ₹ 7.45 as of 04 May 10:54 . The P/E Ratio of Vaishali Pharma Ltd changed from 32.9 on March 2021 to 209.7 on March 2025 . This represents a CAGR of 44.84% over 5 yearsThe P/E Ratio of Vilin Bio Med Ltd changed from 158.3 on March 2024 to 127.5 on March 2025 . This represents a CAGR of -10.25% over 2 years The Market Cap of Vaishali Pharma Ltd changed from ₹ 171.9 crore on March 2021 to ₹ 134.85 crore on March 2025 . This represents a CAGR of -4.74% over 5 yearsThe Market Cap of Vilin Bio Med Ltd changed from ₹ 26.51 crore on March 2024 to ₹ 28.46 crore on March 2025 . This represents a CAGR of 3.61% over 2 years The Revenue of Vaishali Pharma Ltd is ₹ 24.59 crore as of Jun '25 .The Revenue of Vilin Bio Med Ltd is ₹ 0 crore as of Jun '25 . The EBITDA of Vaishali Pharma Ltd is ₹ 2.21 crore as of Jun '25 .The EBITDA of Vilin Bio Med Ltd is ₹ 0 crore as of Jun '25 . The Net Profit of Vaishali Pharma Ltd is ₹ 1.28 crore as of Jun '25 .The Net Profit of Vilin Bio Med Ltd is ₹ 0 crore as of Jun '25 . The Dividend Payout of Vaishali Pharma Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Vilin Bio Med Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Vaishali Pharma Ltd

Vaishali Pharma Limited was originally incorporated as a Private Limited Company with the name 'Vaishali Pharma Private Limited' on 25th, April 2008.
On July 01, 2008 the Company acquired the business of proprietorship concerns of its Promoter Mr. Atul Vasani viz.
M/s.
Vaishali Pharmachem through Business Assignment agreement.
Consequently, the business of said Proprietorship Firm merged into Vaishali Pharma Private Limited.

About Vilin Bio Med Ltd

Vilin Bio Med Limited was originally incorporated on June 29, 2005, which commenced business on July 11, 2005 issued by Registrar of Companies, Andhra Pradesh, Hyderabad.
The Company started its first commercial production in 2006.
In 2007, the Company expanded the Phase 2 for Beta Lactum facility with 16000 sft for Tablet, Capsule and Dry Syrup sections.
In 2010, it acquired more than 1000 molecules Drug Approvals with different strengths in therapeutics of Diabetic, Neuro and Cardio. The Company added the Sachet section in Non-Beta Lactum facility in 2014.
The Company allotted a fresh issue of 40,00,000 Equity Shares of Rs 10/- each by its Initial Public Offering by raising funds aggregating to Rs 12 Crore on June 7, 2023. At present, Company is engaged in domestic business of manufacturing Pharmaceuticals products and the Manufacturing Unit is located in Roorkee, in the State of Uttarakhand.

FAQs for the comparison of Vaishali Pharma Ltd and Vilin Bio Med Ltd

Which company has a larger market capitalization, Vaishali Pharma Ltd or Vilin Bio Med Ltd?

Market cap of Vaishali Pharma Ltd is 99 Cr while Market cap of Vilin Bio Med Ltd is 59 Cr

What are the key factors driving the stock performance of Vaishali Pharma Ltd and Vilin Bio Med Ltd?

The stock performance of Vaishali Pharma Ltd and Vilin Bio Med Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Vaishali Pharma Ltd and Vilin Bio Med Ltd?

As of May 4, 2026, the Vaishali Pharma Ltd stock price is INR ₹7.61. On the other hand, Vilin Bio Med Ltd stock price is INR ₹38.85.

How do dividend payouts of Vaishali Pharma Ltd and Vilin Bio Med Ltd compare?

To compare the dividend payouts of Vaishali Pharma Ltd and Vilin Bio Med Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.